$41.15 -0.31 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - New York Stock Exchange, Inc.

May. 3, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  2. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  3. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  4. Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology

    Benzinga | Jan. 11, 2016 | 05:25AM EST
  5. Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms

    Benzinga | Jan. 11, 2016 | 04:20AM EST
  6. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  7. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  8. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  9. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  10. MannKind Is Plummeting

    Benzinga | Jan. 5, 2016 | 09:19AM EST
  11. Why MannKind Could Be a Value Trap

    GuruFocus | Jan. 4, 2016 | 14:15PM EST
  12. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  13. Sanofi Announces Dengvaxia Dengue Vaccine Approved in Brazil

    Benzinga | Dec. 28, 2015 | 05:33AM EST
  14. Francis Chou's Holdings Trading at Low PE

    GuruFocus | Dec. 23, 2015 | 18:10PM EST
  15. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  16. Microsoft, Intel and National Oilwell Varco Have High Dividend Yields in Bill Nygren's Portfolio

    GuruFocus | Dec. 17, 2015 | 11:54AM EST
  17. Sanofi Enters Negotiations to Swap Merial for Boehringer Ingelheim's Consumer Healthcare Business

    Benzinga | Dec. 15, 2015 | 04:19AM EST
  18. Warren Buffett Further Pares Munich Re Stake

    GuruFocus | Dec. 14, 2015 | 16:52PM EST
  19. Warren Buffett Sells More Munich Re

    GuruFocus | Dec. 14, 2015 | 16:52PM EST
  20. Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection

    Benzinga | Dec. 11, 2015 | 04:13AM EST
  21. Relypsa Stock Jumps On Buyout Rumors

    IBD | Dec. 4, 2015 | 15:31PM EST
  22. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD | Dec. 4, 2015 | 08:02AM EST
  23. U.S.-Traded Eurozone Stocks React Mildly To ECB Vote

    IBD | Dec. 3, 2015 | 18:11PM EST
  24. Sanofi chips at Biogen share

    IBD | Nov. 30, 2015 | 18:53PM EST
  25. Sanofi Chipping Away At Biogen's MS Dominance

    IBD | Nov. 30, 2015 | 11:32AM EST
  26. Must Watch Stocks for November 30, 2015

    Benzinga | Nov. 30, 2015 | 04:16AM EST
  27. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 29, 2015 | 19:44PM EST
  28. Bristol-Myers Looks Beyond Cancer To Build Portfolio

    IBD | Nov. 27, 2015 | 08:02AM EST
  29. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  30. Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled

    Benzinga | Nov. 24, 2015 | 04:21AM EST
  31. CVS Makes Amgen New BFF

    IBD | Nov. 23, 2015 | 18:42PM EST
  32. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD | Nov. 23, 2015 | 16:06PM EST
  33. Weekly 3-Year Low Highlights: Sanofi, Exelon, Cummins, W.W. Grainger

    GuruFocus | Nov. 18, 2015 | 10:59AM EST
  34. Regeneron Tests Buy Point As New Drug Shows Promise

    IBD | Nov. 13, 2015 | 18:24PM EST
  35. Regeneron Recovers From Clinton Biotech Beat Down

    IBD | Nov. 12, 2015 | 11:27AM EST
  36. Gilead, Regeneron Stocks Weather Drug Pricing Furor

    IBD | Nov. 12, 2015 | 08:02AM EST
  37. Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet Rise

    IBD | Nov. 11, 2015 | 08:52AM EST
  38. Sanofi Downgraded After Analyst Day Underwhelms

    IBD | Nov. 9, 2015 | 12:03PM EST
  39. Regeneron, Sanofi Present Positive Results from Pivotal Phase 3 Study of Sarilumab at ACR Annual Meeting

    Benzinga | Nov. 8, 2015 | 08:29AM EST
  40. Mid-Morning Market Update: Markets Decline; Humana Earnings Beat Estimates

    Benzinga | Nov. 6, 2015 | 10:03AM EST
  41. US Stock Futures Surge Ahead Of Jobless Claims Data

    Benzinga | Nov. 5, 2015 | 07:22AM EST
  42. Sanofi,Hanmi Announce License Agreement to Develop Portfolio Of Long-Acting Diabetes Treatments

    Benzinga | Nov. 5, 2015 | 05:55AM EST
  43. Regeneron Q3 Beats Views, But Praluent Launch Slow

    IBD | Nov. 4, 2015 | 15:41PM EST
  44. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD | Nov. 3, 2015 | 08:02AM EST
  45. Diabetes hits drugmakers

    IBD | Oct. 29, 2015 | 18:51PM EST
  46. Sanofi, Novo Nordisk Slide On Diabetes Headwinds

    IBD | Oct. 29, 2015 | 12:40PM EST
  47. Why Rental Rates At Biotech Labs Are Skyrocketing

    IBD | Oct. 15, 2015 | 15:50PM EST
  48. Indexes Close Up Across The Board; Facebook Gains, But Twitter Falls

    IBD | Oct. 12, 2015 | 16:31PM EST
  49. Gilead, GoPro, Twitter Top The Week's Insider Deals

    IBD | Oct. 9, 2015 | 14:26PM EST
  50. Sanofi's Genzyme Reports Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting MS who Received Genzyme's Lemtrada

    Benzinga | Oct. 8, 2015 | 05:00AM EST
Trading Center